What is Tirzepatide?
Tirzepatide is the active ingredient found in the brand-name medications Mounjaro and Zepbound, both FDA-approved prescription-only medications. In SURMOUNT-1, adults with obesity or overweight and a weight-related complication, without diabetes, receiving once-weekly subcutaneous tirzepatide 15 mg had a mean 20.9% weight reduction at 72 weeks, versus 3.1% with placebo. Both groups received a reduced-calorie diet and physical activity counseling. Read the SURMOUNT-1 trial. This is evidence for the tirzepatide regimen studied for weight management, corresponding to Zepbound, rather than Mounjaro diabetes outcomes. These trial results do not establish outcomes for Doko compounded medication or its program. Results vary and are not guaranteed.
In clinical results, one-third of patients using Tirzepatide lost at least 25% of their baseline weight, which can represent major progress for patients who need structured medical support.
Start Losing Weight with Tirzepatide Home Kits Starting from Only $116
Medication type: compounded tirzepatide. The prices below apply to compounded medication, not brand-name Zepbound or Mounjaro. Treatment is subject to clinician evaluation and prescription.
Separate Tirzepatide pricing with medication, supplies, consultation, and baseline bloodwork included from the start.
$116Starter Program
2.5mg
4 weekly injections (2.5mg each)
Monthly total: 10mg
$128Standard Program
5mg
4 weekly injections (5mg each)
Monthly total: 20mg
$139Advanced Program
7.5mg
4 weekly injections (7.5mg each)
Monthly total: 30mg
$151Elite Program
10mg
4 weekly injections (10mg each)
Monthly total: 40mg
$162Performance Program
12.5mg
4 weekly injections (12.5mg each)
Monthly total: 50mg
$168Max Protocol
15mg
4 weekly injections (15mg each)
Monthly total: 60mg
Telehealth Session
Benefits of Tirzepatide for Weight Loss
- Weight-management evidence: The SURMOUNT-1 result above applies to the studied dose, population and lifestyle intervention.
- Product-specific treatment: Mounjaro and Zepbound have different approved indications. Discuss the exact prescribed product with your clinician.
- Individual assessment: Your clinician should assess potential benefits, side effects and monitoring needs. This program does not promise prevention of diabetes or cardiovascular events.
